Copenhagen Stock Exchange:NOVO B

<!-- Name:DistributionId Value:1000795783 --> <!-- Name:NewsArchiveTags Value:1491,5355 --> <!-- Name:NewsArchiveOrgTags…

<!-- Name:DistributionId Value:1000784124 --> <!-- Name:NewsArchiveTags Value:1491,5356 --> <!-- Name:NewsArchiveOrgTags…

<!-- Name:DistributionId Value:1000781927 --> <!-- Name:NewsArchiveTags Value:1491,5355 --> <!-- Name:NewsArchiveOrgTags…

<!-- Name:DistributionId Value:1000780712 --> <!-- Name:NewsArchiveTags Value:6134 --> <!-- Name:NewsArchiveOrgTags…

<!-- Name:DistributionId Value:1000780106 --> <!-- Name:NewsArchiveTags Value:1491,5356 --> <!-- Name:NewsArchiveOrgTags…

Bagsværd, Denmark, 09 January 2023 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the…

Bagsværd, Denmark, 04 November 2022 – Today, Novo Nordisk A/S has entered into an agreement to purchase 4,207,500 B shares of DKK 0.20 at a value of DKK 3,582 million from Novo Holdings A/S. The transaction is part of Novo Nordisk A/S’…

Bagsværd, Denmark, 4 November 2022 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2022 of DKK 24 billion continues. As part of this, Novo Nordisk A/S has now initiated a new share repurchase programme of up…

Bagsværd, Denmark, 4 November 2022 – This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation…